Investments
9Portfolio Exits
9Partners & Customers
10About DSM
On May 31st, 2022, Royal DSM merged with Firmenich to create DSM-Firmenich. DSM (OTCMKTS: RDSMY) is a science-based company active in health, nutrition, and materials. DSM delivers solutions that nourish, protect, and improve performance in global markets, such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy, and bio-based materials. It was founded in 1902 and is based in Heerlen, Netherlands.
DSM Headquarter Location
Het Overloon 1
Heerlen, 6411 TE,
Netherlands
+31-0-45-578-8111
Expert Collections containing DSM
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find DSM in 1 Expert Collection, including Medical Devices.
Medical Devices
8,451 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
DSM Web Traffic
DSM Rank
Research containing DSM
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned DSM in 1 CB Insights research brief, most recently on Feb 26, 2020.
Latest DSM News
Aug 5, 2022
Market Competition Key players in the global alternative protein industry are Cargill Incorporation, Royal DSM NV, AMCO Proteins, Puris, Axiom Foods, Darling Ingredients, Innovafeed, Lallemand Inc, Hamlet Protein, Archer Daniel Midland Company, AB Mauri, Soja Protein, Ingredion, Ynsect, Angel Yeast, and Calysta Inc. Cargill Incorporation, a key player has introduced pea protein in the Asia market. The pea protein comprises of non-GMO features and has low allergenic. The protein is highly versatile and can be used in different food preparation. Royal DSM NV launched CanolaPRO, a plant-based protein source from canola (rapeseed). The protein is gluten-free, non-dairy, Non-GMO and offers a mouthfeel texture. More Insights Available FMI, in its new offering, presents an unbiased analysis of the global alternative protein market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032. The study reveals essential insights on the basis of by Source (Insect-based, Microbial-based, Plant-based, others) by application (Food & beverages, Cattle, Aquaculture, Animal Feed, Pet food, Equine, Others) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). Key Segments Profiled in the Alternative Protein Market Industry Survey Alternative Protein Market by Source: Insect-based Alternative Protein 4.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis Have a Look at Food and Beverage Domain Related Research Reports: Pea Protein Ingredients Market Size : Sales in the pea protein ingredients market are estimated to total US$ 1.25 Bn in 2021. As per Future Market Insights (FMI), the overall market value is expected to reach US$ 2.5 Bn by 2031 Soy Protein Ingredient Market Trends : The soy protein ingredients often serve as an alternative to animal protein in the global market, owing to its organic nature. Pea Protein Market Outlook : The pea protein market revenue totaled US$ 3.2 Bn in 2021, according to Future Market Insights (FMI). Exhibiting a CAGR of 14.2% for 2021-31, the market is expected to reach US$ 12.31 Bn by 2031. Dry Mixes Market Forecast : The global dry mixes market is anticipated to be valued at US$ 8,700.0 Million in 2022, forecast to grow at a CAGR of 5.9% to be valued at US$ 15,434.0 Million from 2022 to 2032. Melaleuca Alternif olia Market Shares : The melaleuca alternifolia market is anticipated to achieve a CAGR of 7.4% through 2032 and is expected to reach a value of US$ 48 Million in 2022. By 2032, the melaleuca alternifolia market size is projected to increase to US$ 98 Million. Catalase Market Type : The global catalase market is anticipated to be valued at US$ 387.4 Million in 2022, forecast to grow at a CAGR of 2.9% to be valued at US$ 516.6 Million from 2022 to 2032. Squash Market Demand : The global squash market is forecasted to be valued at US$ 1,510.6 Mn by 2032, up from US$ 1,027.6 Mn in 2022, advancing at a CAGR of 4.7% during the forecast period. Cassia Seed Extract Market Analysis : Global cassia seed extract demand is anticipated to be valued at US$ 395.7 Million in 2022, forecast to grow at a CAGR of 6.2% to be valued at US$ 641.0 Million from 2022 to 2032. Liquid Feed Supplements Market Technology : The global liquid feed supplements market is anticipated to hold a value of US$ 5,918.2 Million in 2022 and reach US$ 9,732.3 Million by 2032. L-Lysine Hydrochloride (HCL) Market Growth : Global L-Lysine Hydrochloride (HCL)’ demand is anticipated to be valued at US$ 240.6 Million in 2022, forecast to grow at a CAGR of 4.2% to be valued at US$ 341.7 Million from 2022 to 2032. Download complimentary copy of Future Market Insights White Paper in collaboration with PBFIA, on the Plant Based Market that throws light on potential opportunities and investments made in the Global plant based market About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact:
DSM Investments
9 Investments
DSM has made 9 investments. Their latest investment was in Veramaris as part of their Corporate Minority on October 10, 2019.
DSM Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/23/2019 | Corporate Minority | Veramaris | Yes | 1 | ||
2/18/2019 | Series A | |||||
11/8/2018 | Corporate Minority - II | |||||
7/2/2018 | Corporate Minority | |||||
5/4/2017 | Unattributed |
Date | 10/23/2019 | 2/18/2019 | 11/8/2018 | 7/2/2018 | 5/4/2017 |
|---|---|---|---|---|---|
Round | Corporate Minority | Series A | Corporate Minority - II | Corporate Minority | Unattributed |
Company | Veramaris | ||||
Amount | |||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 1 |
DSM Portfolio Exits
9 Portfolio Exits
DSM has 9 portfolio exits. Their latest portfolio exit was Royal DSM - Engineering on May 31, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/31/2022 | Divestiture | Royal DSM - Engineering | 3 | ||
Date | 5/31/2022 | ||||
|---|---|---|---|---|---|
Exit | Divestiture | ||||
Companies | Royal DSM - Engineering | ||||
Valuation | |||||
Acquirer | |||||
Sources | 3 |
DSM Acquisitions
24 Acquisitions
DSM acquired 24 companies. Their latest acquisition was Prodap on June 07, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
6/7/2022 | Acquired | 1 | ||||
11/29/2021 | Acquired | 13 | ||||
9/3/2021 | Acquired | 3 | ||||
7/27/2021 | ||||||
3/31/2021 |
Date | 6/7/2022 | 11/29/2021 | 9/3/2021 | 7/27/2021 | 3/31/2021 |
|---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acquired | Acquired | Acquired | ||
Sources | 1 | 13 | 3 |
DSM Partners & Customers
10 Partners and customers
DSM has 10 strategic partners and customers. DSM recently partnered with HCL Technologies on July 7, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
7/18/2022 | Vendor | India | 5 | ||
5/13/2022 | Partner | United States | Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia . | 1 | |
4/28/2022 | Licensor | United States | Elanco has secured the exclusive US licensing rights to develop , manufacture and commercialize Royal DSM 's methane-reduction product Bovaer for beef and dairy cattle . | 1 | |
4/27/2022 | Licensee | ||||
4/27/2022 | Licensee |
Date | 7/18/2022 | 5/13/2022 | 4/28/2022 | 4/27/2022 | 4/27/2022 |
|---|---|---|---|---|---|
Type | Vendor | Partner | Licensor | Licensee | Licensee |
Business Partner | |||||
Country | India | United States | United States | ||
News Snippet | Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia . | Elanco has secured the exclusive US licensing rights to develop , manufacture and commercialize Royal DSM 's methane-reduction product Bovaer for beef and dairy cattle . | |||
Sources | 5 | 1 | 1 |
DSM Team
32 Team Members
DSM has 32 team members, including current President, Chief Financial Officer, Senior Vice President, Eros Carletti.
Name | Work History | Title | Status |
|---|---|---|---|
Eros Carletti | President, Chief Financial Officer, Senior Vice President | Current | |
Maha Elkharbotly | Senior Vice President | Current | |
Harry Relouw | Controller | Current | |
JaKela Walker | Senior Director | Current | |
Marc Andre Lebel | Aspen Aerogels, Triton Systems, Cabot Corporation, and Nova Chemicals | Chief Executive Officer, President | Former |
Name | Eros Carletti | Maha Elkharbotly | Harry Relouw | JaKela Walker | Marc Andre Lebel |
|---|---|---|---|---|---|
Work History | Aspen Aerogels, Triton Systems, Cabot Corporation, and Nova Chemicals | ||||
Title | President, Chief Financial Officer, Senior Vice President | Senior Vice President | Controller | Senior Director | Chief Executive Officer, President |
Status | Current | Current | Current | Current | Former |
You May Also Like
Biosyntia develops bio-catalysts intended to produce complex chemical compounds by fermentation. The company assists in the production of chemical compounds including flavors, fragrances, APIs, pigments, additives, intermediates, and vitamins by applying synthetic biology and metabolic engineering, enabling clients to establish greener and sustainable manufacturing processes for their production purposes in reduced production costs and environmental impact. Biosyntia was founded in 2012 and is based in Copenhagen, Denmark.
Evolva Holding develops and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally.
Ginkgo Bioworks (NYSE: DNA) designs and prints DNA. The company can design the living code to build custom microorganisms with lower environmental impact and waste for customers in a wide range of industries including pharmaceuticals, consumer goods, consumer electronics, cosmetics, nutrition, food, agriculture, medicine, and more. The company was founded in 2009 and is based in Boston, Massachusetts.
Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) provides a research platform that reinvents the production of active pharmaceutical ingredient (API) supplies for global pharmaceutical, health and wellness, and consumer packaged goods industries. The company focuses on the production of pure CBD, with plans to target many more plant-sourced drugs in the future.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.